Latest TEVA reports update at 2024-05-08: 2024-Q1 ∙ 2023-Q1

Teva Pharmaceutical Industries Limited TEVA

$ 16.0 1.65%

Teva Pharmaceutical Industries Limited Cost of Revenue 2011-2024 | TEVA

Annual Cost of Revenue Teva Pharmaceutical Industries Limited

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
8.2 B	7.95 B	8.28 B	8.93 B	9.35 B	9.98 B	11.2 B	10.2 B	8.3 B	9.22 B	9.61 B	9.66 B	8.8 B

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
11.2 B	7.95 B	9.21 B

Quarterly Cost of Revenue Teva Pharmaceutical Industries Limited

2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
2.05 B	2 B	2.08 B	2.08 B	-	1.93 B	1.99 B	1.92 B	-	2.09 B	2.04 B	2.1 B	-	2.13 B	2.11 B	2.29 B	-	2.26 B	2.28 B	2.29 B	-	2.55 B	2.67 B	2.75 B	-	2.97 B	2.86 B	2.81 B	-	2.76 B	2.16 B	2.02 B	-	2.05 B	2.06 B	2.15 B	-	2.25 B	2.38 B	2.3 B	-	2.43 B	2.33 B	2.31 B	-	2.37 B	2.34 B	2.49 B	-	2.1 B	2.01 B	1.89 B

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.97 B	1.89 B	2.27 B